EUVIMEDEUVIMED entdecken
Crossref

RNA-Sequencing Analysis Identification of Potential Biomarkers for Diagnosis of Sarcopenia

Motoki Furutani, Mutsumi Suganuma, Shintaro Akiyama, Risa Mitsumori, Marie Takemura, Yasumoto Matsui, Shosuke Satake, Yukiko Nakano, Shumpei Niida iD, Kouichi Ozaki, Tohru Hosoyama, Daichi Shigemizu iD

The Journals of Gerontology: Series A · 28.10.2023 · 78 (11) · 1991-1998

DOI: 10.1093/gerona/glad150 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journals of Gerontology: Series A, online erschienen am 22.06.2023. Verfasst von Motoki Furutani und 11 weiteren Autor:innen. Beteiligte Einrichtung: Medical Genome Center, Research Institute, National Center for Geriatrics and Gerontology, Aichi, Japan. Hauptthemen laut MEDLINE: Sarcopenia. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Japan Health Research Promotion Bureau, Japanese Ministry of Health, Labour, and Welfare for Research on Dementia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sarcopenia is a geriatric disease associated with increased mortality and disability. Early diagnosis and intervention are required to prevent it. This study investigated biomarkers for sarcopenia by using a combination of comprehensive clinical data and messenger RNA-sequencing (RNA-seq) analysis obtained from peripheral blood mononuclear cells. We enrolled a total of 114 older adults aged 66–94 years (52 sarcopenia diagnosed according to the Asian Working Group for Sarcopenia 2019 consensus and 62 normal older people). We used clinical data which were not included diagnosis criteria of sarcopenia, and stride length showed significance by logistic regression analysis (Bonferroni corrected p = .012, odds ratio = 0.14, 95% confidence interval [CI]: 0.05–0.40). RNA-seq analysis detected 6 differential expressed genes (FAR1, GNL2, HERC5, MRPL47, NUBP2, and S100A11). We also performed gene-set enrichment analysis and detected 2 functional modules (ie, hub genes, MYH9, and FLNA). By using any combination of the 9 candidates and basic information (age and sex), risk-prediction models were constructed. The best model by using a combination of stride length, HERC5, S100A11, and FLNA, achieved a high area under the curve (AUC) of 0.91 in a validation cohort (95% CI: 0.78–0.95). The quantitative PCR results of the 3 genes were consistent with the trend observed in the RNA-seq results. When BMI was added, the model achieved a high AUC of 0.95 (95% CI: 0.84–0.99). We have discovered potential biomarkers for the diagnosis of sarcopenia. Further refinement may lead to their future practical use in clinical use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaHumansAgedLeukocytes, MononuclearBiomarkersHand StrengthRNA

Stichwörter der Autor:innen

Blood-based biomarkerPrediction modelRNA sequencingSarcopenia

Substanzen

BiomarkersRNA

Autor:innen und Institutionen

  • Medical Genome Center, Research Institute, National Center for Geriatrics and Gerontology, Aichi, Japan.
  • Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
  • Center for Frailty and Locomotive Syndrome, National Center for Geriatrics and Gerontology, Aichi, Japan.
  • Center for Gerontology and Social Science, Research Institute, National Center for Geriatrics and Gerontology, Aichi, Japan.
  • Core Facility Administration, Research Institute, National Center for Geriatrics and Gerontology, Aichi, Japan.
  • RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.

ORCID-Profile: Shumpei Niida, Daichi Shigemizu

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Health Research Promotion Bureau
  • Japanese Ministry of Health, Labour, and Welfare for Research on Dementia
  • Japan Society for the Promotion of Science

Zitieren

APA

Furutani, M., Suganuma, M., Akiyama, S., Mitsumori, R., Takemura, M., Matsui, Y., Satake, S., Nakano, Y., Niida, S., Ozaki, K., Hosoyama, T., & Shigemizu, D. (2023). RNA-Sequencing Analysis Identification of Potential Biomarkers for Diagnosis of Sarcopenia. The Journals of Gerontology: Series A, 78(11), 1991-1998. https://doi.org/10.1093/gerona/glad150

Vancouver

Furutani M, Suganuma M, Akiyama S, Mitsumori R, Takemura M, Matsui Y, et al. RNA-Sequencing Analysis Identification of Potential Biomarkers for Diagnosis of Sarcopenia. The Journals of Gerontology: Series A. 2023;78(11):1991-1998. doi:10.1093/gerona/glad150

BibTeX
@article{Furutani2023,
  author = {Furutani, Motoki and Suganuma, Mutsumi and Akiyama, Shintaro and Mitsumori, Risa and Takemura, Marie and Matsui, Yasumoto and Satake, Shosuke and Nakano, Yukiko and Niida, Shumpei and Ozaki, Kouichi and Hosoyama, Tohru and Shigemizu, Daichi},
  title = {RNA-Sequencing Analysis Identification of Potential Biomarkers for Diagnosis of Sarcopenia},
  journal = {The Journals of Gerontology: Series A},
  year = {2023},
  volume = {78},
  number = {11},
  pages = {1991--1998},
  doi = {10.1093/gerona/glad150}
}
Kostenlos starten →